Evidence map›Paper›PMID 28752842›Full record

ArticleModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2017

USP6 activation in nodular fasciitis by promoter-swapping gene fusions.

Nimesh R Patel, John S A Chrisinger, Elizabeth G Demicco, Stephen F Sarabia, Jacquelyn Reuther, Erica Kumar, Andre M Oliveira, Steven D Billings, Judith V M G Bovée, Angshumoy Roy and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 120 citations in OpenAlex.

  1. Article
  2. Uncommon location, diagnostic challenge: A case series of acral low-grade fibromyxoid sarcoma.Virchows Archiv : an international journal of pathology · 2026
    Article
  3. Article
  4. Nodular fasciitis of the intradural cervical spine with *MIR22HG::USP6* fusion a rare postoperative occurrence and novel molecular pathogenesis.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2026
    Article
  5. Article
  6. Article
  7. Solitary fibrous tumor: an updated review.Journal of pathology and translational medicine · 2026
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 2 countries.

Nimesh R PatelDepartment of Pathology, Texas Children's Hospital, Houston, TX, USA.
John S A ChrisingerDepartment of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Elizabeth G DemiccoDepartment of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Stephen F SarabiaDepartment of Pathology, Texas Children's Hospital, Houston, TX, USA.
Jacquelyn ReutherDepartment of Pathology, Texas Children's Hospital, Houston, TX, USA.
Erica KumarDepartment of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Andre M OliveiraDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Steven D BillingsDepartment of Pathology, Cleveland Clinic, Cleveland, OH, USA.
Judith V M G BovéeDepartment of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
Angshumoy RoyDepartment of Pathology, Texas Children's Hospital, Houston, TX, USA.
Alexander J LazarDepartment of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Dolores H Lopez-TerradaDepartment of Pathology, Texas Children's Hospital, Houston, TX, USA.
Wei-Lien WangDepartment of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
The University of Texas MD Anderson Cancer Center · USBaylor College of Medicine · USCleveland Clinic · USLeiden University Medical Center · NLMayo Clinic in Arizona · USTexas Children's Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nodular fasciitis is a self-limited myofibroblastic lesion that can be misdiagnosed as a sarcoma as a result of its rapid growth, cellularity, and sometimes prominent mitotic activity. A recurrent translocation t(17;22) has been identified in nodular fasciitis, fusing the coding region of USP6 to the promoter region of MYH9, and resulting in increased USP6 expression. A subset of cases show USP6 rearrangement without the typical fusion variants by RT-PCR, or any MYH9 rearrangement by FISH. We sought to further characterize such tumors using molecular diagnostic assays. A novel RT-PCR assay was designed to detect the two known MYH9-USP6 fusion types in formalin-fixed paraffin-embedded and frozen tissue, and a break-apart FISH assay was designed to detect USP6 rearrangement. Twenty-six cases of nodular fasciitis diagnosed between 2002 and 2013 were retrieved from the pathology files of our institutions and were confirmed to be positive by FISH and/or RT-PCR. Seven samples showed USP6 rearrangement by FISH but were negative for MYH9-USP6 fusion by RT-PCR; these cases were subjected to a next-generation sequencing assay utilizing anchored multiplex PCR technology. This assay targets a single partner gene associated with fusions in bone and soft tissue tumors for agnostic detection of gene fusion partners. Novel fusion partners were identified in all seven cases and confirmed by RT-PCR. Structurally, all fusions consisted of the juxtaposition of the entire coding region of USP6 with the promoter of the partner gene, driving increased USP6 expression. This study confirms the neoplastic nature of nodular fasciitis, defines additional pathogenic fusion partners, and adds to the growing body of literature on USP6-associated neoplasia. Given the diagnostic challenges of these tumors, molecular assays can be useful ancillary tools; however, the prevalence of promoter swapping must be recognized when interpreting results.

Indexed as

AdolescentAdultAgedChildFasciitisFemaleHumansMaleMiddle AgedMyofibromaOncogene FusionOncogene Proteins, FusionPromoter Regions, GeneticProto-Oncogene ProteinsTranslocation, GeneticUbiquitin ThiolesteraseOncogene Proteins, FusionProto-Oncogene ProteinsUbiquitin ThiolesteraseUSP6 protein, human

Identifiers

PMID28752842
OpenAlexW2740577806

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.